There is no clearly effective and low risk treatment for ischemic stroke. Thrombolysis may establish early reperfusion, but may also increase the risk of intracerebral hemorrhage and death. These studies focus on local leukocyte adhesion receptor expression, thrombosis, and impaired fibrinolysis as a cause for cerebral microvascular failure. Pilot data with mice subjected to focal cerebral ischemia/reperfusion demonstrate that P-selectin and intercellular adhesion molecule-1 (ICAM-1) expression induce leukocyte capture, postischemic no-reflow, and tissue injury. In addition, fibrin accumulates in the cerebral microvasculature, due largely to integrin GPIIb/IIIa receptor-mediated platelet aggregation and impaired fibrinolysis due to increased local plasminogen activator-inhibitor-1 (PAI-1) expression. Mice deficient for the PAI-1 gene are relatively resistant to ischemic cerebral injury, in contrast to mice lacking the tissue plasminogen activator (tPA)gene. Blockade of GPIIb/IIIa reduces local platelet and fibrin accumulation, conferring cerebral protection Because leukocytes promote thrombosis by interacting with platelets and modulating the local thrombotic/fibrinolytic balance, they hypothesize that leukocyte recruitment and thrombosis synergize to exacerbate cerebral injury following stroke. Preliminary evidence for this synergy is that P-selectin null mice exhibit reduced cerebral thrombosis in stroke.Using this murine model of stroke, the Specific Aims will establish; (1) the role of microvascular thrombosis, examining endogenous modulators of fibrinolysis (using control, tPA, uPA, and PAI-1-deficient mice) and rt-PA or a selective GPIIb/IIIa antagonist; (2) the role of leukocytes and adhesion receptors, using mice deficient for adhesion receptors or counterligands (P-selectin, ICAM-1, ICAM-2, CD18) and novel antiinflammatory strategies (IL-1 receptor blockade and a hybrid molecule to inhibit complement activation and P-selectin). Studies will assess whether leukocytes activate local proinflammatory signal transduction mechanisms such as nuclear factor kB (NF-kB); (3) whether thrombosis, fibrinolysis, and leukocyte recruitment act synergistically, establishing if endogenous fibrinolytic mechanisms alter leukocyte recruitment (or conversely, if leukocyte capture modulates thrombosis), determining if adhesion receptor blockade can minimize the dose of rt-PA needed for cerebral protection. Overall, studies should provide a new stroke paradigm regarding the pathogenic roles of adhesion receptors and microvascular thrombosis, to guide the development of new strategies to interfere with leukocyte adhesion, inflammation, and microvascular thrombosis in evolving stroke.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL059488-02
Application #
6056470
Study Section
Neurology A Study Section (NEUA)
Program Officer
Jacobs, Tom P
Project Start
1998-09-30
Project End
2002-08-31
Budget Start
1999-09-01
Budget End
2000-08-31
Support Year
2
Fiscal Year
1999
Total Cost
Indirect Cost
Name
Columbia University (N.Y.)
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
167204994
City
New York
State
NY
Country
United States
Zip Code
10032
Ducruet, Andrew F; Sosunov, Sergey A; Visovatti, Scott H et al. (2011) Paradoxical exacerbation of neuronal injury in reperfused stroke despite improved blood flow and reduced inflammation in early growth response-1 gene-deleted mice. Neurol Res 33:717-25
Liao, Hui; Hyman, Matthew C; Lawrence, Daniel A et al. (2007) Molecular regulation of the PAI-1 gene by hypoxia: contributions of Egr-1, HIF-1alpha, and C/EBPalpha. FASEB J 21:935-49
Harada, Hiroaki; Lama, Vibha N; Badri, Linda N et al. (2007) Early growth response gene-1 promotes airway allograft rejection. Am J Physiol Lung Cell Mol Physiol 293:L124-30
Mishra, Snigdha; Fujita, Tomoyuki; Lama, Vibha N et al. (2006) Carbon monoxide rescues ischemic lungs by interrupting MAPK-driven expression of early growth response 1 gene and its downstream target genes. Proc Natl Acad Sci U S A 103:5191-6
Mocco, J; Mack, William J; Ducruet, Andrew F et al. (2006) Complement component C3 mediates inflammatory injury following focal cerebral ischemia. Circ Res 99:209-17
Marcus, Aaron J; Broekman, M Johan; Drosopoulos, Joan H F et al. (2005) Role of CD39 (NTPDase-1) in thromboregulation, cerebroprotection, and cardioprotection. Semin Thromb Hemost 31:234-46
Ten, Vadim S; Sosunov, Sergei A; Mazer, Sean P et al. (2005) C1q-deficiency is neuroprotective against hypoxic-ischemic brain injury in neonatal mice. Stroke 36:2244-50
Ten, Vadim S; Wu, Ed X; Tang, Haiying et al. (2004) Late measures of brain injury after neonatal hypoxia-ischemia in mice. Stroke 35:2183-8
Marcus, A J; Broekman, M J; Drosopoulos, J H F et al. (2003) Heterologous cell-cell interactions: thromboregulation, cerebroprotection and cardioprotection by CD39 (NTPDase-1). J Thromb Haemost 1:2497-509
Ten, Vadim S; Bradley-Moore, Maria; Gingrich, Jay A et al. (2003) Brain injury and neurofunctional deficit in neonatal mice with hypoxic-ischemic encephalopathy. Behav Brain Res 145:209-19

Showing the most recent 10 out of 39 publications